v3.26.3
Restatement of Prior Period Financial Statements - Consolidated Statements of Changes in Shareholders' Equity (Details) - CAD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Total Shareholders' Equity    
Balance balance $ 6,269,397 $ 2,608,080
Common share financings, net (Note 17) 11,653,658 21,381,446
Warrant exercise (Note 18) 3,392,617 139,250
Warrant amendment (Note 16) 20,710,982  
Option exercises (Note 18) 4,480,370 1,275,341
Stock-based compensation (Note 18) 3,603,619 4,529,991
Loss and comprehensive loss (44,214,333) (23,664,711)
Balance ending 5,896,310 6,269,397
As Previously Stated    
Total Shareholders' Equity    
Balance balance 2,576,607 (2,009,105)
Common share financings, net (Note 17) 9,681,548 21,381,446
Warrant exercise (Note 18) 3,392,617 139,250
Warrant amendment (Note 16) 22,068,176  
Option exercises (Note 18) 4,480,370 1,275,341
Stock-based compensation (Note 18) 5,394,914 6,039,724
Loss and comprehensive loss (44,117,305) (24,250,049)
Balance ending 3,476,926 2,576,607
Restatement Adjustments    
Total Shareholders' Equity    
Balance balance 3,692,790 4,617,185
Common share financings, net (Note 17) 1,972,110  
Warrant amendment (Note 16) (1,357,194)  
Stock-based compensation (Note 18) (1,791,295) (1,509,733)
Loss and comprehensive loss (97,028) 585,338
Balance ending $ 2,419,384 $ 3,692,790